Wataru Endo adds to Liverpool injury woes
Digest more
Anfield Watch on MSN
Liverpool midfielder's future plunged into serious doubt
Will we ever see Endo play for the Reds again?
NEW YORK (Reuters) - Bankrupt drugmaker Endo International said on Wednesday the federal government's opposition to its bankruptcy sale threatened to undo nearly $600 million in settlements reached with states and people afflicted by the U.S. opioid crisis.
Endo International (OTC:ENDPQ) has gained approval from U.S. Bankruptcy Court Judge James Garrity to initiate the solicitation of votes for its restructuring plan. Endo's restructuring plan outlines a $600 million trust to compensate creditors ...
Endo International, a pharmaceutical company whose U.S. headquarters is in Malvern, Pennsylvania, has agreed to pay the government up to $465 million to settle civil and criminal investigations into the sales and marketing of an opioid drug, federal ...
Having spent the better part of the decade grappling with bankruptcy bids and opioid settlements, troubled drugmakers Mallinckrodt and Endo have decided to join forces to create a more flexible company and ultimately spin off their sizeable generics businesses
Wataru Endo was eager to get home. “It was a big day today as my four kids started at their new school,” the amiable Liverpool midfielder tells The Athletic. “I haven’t heard yet how they found it, but I’m looking forward to hearing all about it.